EGFR-targeted gelatin nanoparticles observation method and process Dr. Huda Begam

Authors

  • Dr. Huda Begam

Keywords:

EGFR targeting, gelatin nanoparticles, GE11 peptide, cancer therapy, nanoparticle characterization, drug delivery, analytical methods, TEM analysis, cellular uptake

Abstract

Epidermal growth factor receptor (EGFR)-targeted gelatin nanoparticles represent a promisingapproach for cancer therapy through selective drug delivery to EGFR-overexpressing tumorcells. This research paper comprehensively examines the observation methods and analytical

References

Siegel, R.L., Miller, K.D., Wagle, N.S., Jemal, A. Cancer statistics, 2023. CA: A Cancer Journal for Clinicians. 2023;73(1):233-254. https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21763

Mitchell, M.J., Billingsley, M.M., Haley, R.M., Wechsler, M.E., Peppas, N.A., Langer, R. Engineering precision nanoparticles for drug delivery. Nature Reviews Drug Discovery. 2021;20(2):101-124. https://www.nature.com/articles/s41573-020-0090-8

Downloads

Published

2025-07-22

How to Cite

Dr. Huda Begam. (2025). EGFR-targeted gelatin nanoparticles observation method and process Dr. Huda Begam . Journal of Computational Analysis and Applications (JoCAAA), 34(7), 114–132. Retrieved from https://www.eudoxuspress.com/index.php/pub/article/view/3279

Issue

Vol. 34 No. 7 (2025): JOCAAA

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.